Australia · Delayed Price · Currency is AUD Saluda Medical Company Description
Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally.
The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback.
It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden.
The company was founded in 2011 and is based in Bloomington, Minnesota.
| Country | United States |
| Founded | 2011 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 133 |
| CEO | Michael Mathias |
Contact Details
Address: 9401 James Avenue S Bloomington, Minnesota 55431 United States | |
| Phone | (857) 272-9585 |
| Website | saludamedical.com |
Stock Details
| Ticker Symbol | SLD |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | AU0000432114 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Barry J. Regan | Chief Executive Officer, President and Director |
| James Erickson | Chief Financial Officer |
| Aidan O'Sullivan | Chief Operations Officer |
| Dean Karantonis | Chief Technology Officer |
| Kristin S. Caplice | Chief Legal Officer and Secretary |
| David First | Chief People Officer |
| Michael Mathias | Chief Commercial Officer |